Superworth

Petmed Express PE ratio PETS

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026
n/m
losses over the last year
Last meaningful
242×
Oct 2025
10-year median
21.7×
10-year range
8.2× to 442×
Peer median
12.8×

Petmed Express has no meaningful PE ratio today: it lost $1.38 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Oct 2025, at 242×.

On the days it had one over the last ten years, its median was 21.7×, from 8.2× in Jul 2019 to 442× in Feb 2025.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2025242×242×442×
2024n/m a value too high to mean anything
202325.8×23.7×35.0×
202222.7×18.5×27.3×
202120.2×18.2×24.8×
202021.4×18.1×31.7×
201917.9×8.2×18.2×
201811.5×10.8×35.7×
201730.5×18.1×41.3×
201621.6×16.1×21.6×
201517.1×16.2×20.5×
201416.9×13.9×18.0×
201318.0×14.4×19.5×
201213.7×12.1×15.7×

Against its peers

Companies in Healthcare nearest Petmed Express' size, closest first, today.

CompanyPE ratio
PETSPetmed Expressn/m
NEPHNephros22.1×
ATNMActinium Pharmaceuticals4.2×
APTAlpha Pro Tech13.6×
SPROSpero Therapeutics10.1×
LFVNLifevantage14.7×
ICCCImmucell128×
KEQUKewaunee Scientific11.9×
PDEXPro DEX15.1×
PLXProtalix BioTherapeutics11.1×
NATRNatures Sunshine Products12.0×
Peer median12.8×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Petmed Express

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.